FastMarket.news

Trump Urges Walmart to Bear Tariff Costs Amid Inflation Concerns

Published 2 hours agoWMT
Trump Urges Walmart to Bear Tariff Costs Amid Inflation Concerns

President Donald Trump recently advised Walmart to absorb the costs of tariffs on imported goods rather than passing them onto consumers. On May 17, 2025, Trump criticized Walmart's plan to increase prices due to heightened tariffs and suggested that both the retail giant and China should "eat the tariffs" to avoid burdening shoppers, as reported by Reuters.


Walmart had announced potential price hikes starting later this month, attributing the decision to increased import tariffs. However, when asked about the President's comments, a representative for Walmart did not immediately provide a response. This development closely aligns with a significant drop in U.S. consumer sentiment, which has now plunged to its second-lowest level on record as consumers grow increasingly anxious over rising inflation and potential job losses, according to the Financial Times.


The unfolding situation poses challenges for the retail sector, with Walmart's strategy on handling these tariffs under scrutiny. How the company navigates this issue could provide insights into the retail sector's broader response to trade tensions and its ability to sustain consumer trust in an uncertain economic climate.

Share this article

Recent Articles

Analysts Show Optimism for Enliven Therapeutics with Increased Price Targets

Analysts Show Optimism for Enliven Therapeutics with Increased Price Targets

5 minutes agoENLV

Contrary to rumors of a price target cut by JonesResearch, recent analyst activities suggest a more positive outlook for Enliven Therapeutics with several firms updating their estimates. Baird notably raised its price target for the company from $32 to $40 on November 15, 2024, while maintaining an "Outperform" rating, according to nasdaq.com. This adjustment reflects a continued belief in the company's potential. Additionally, HC Wainwright joined this optimistic trend by increasing its price target for Enliven from $37 to $39 on March 21, 2025. The firm assigned a "Buy" rating, further underscoring the confidence within the financial community. These updates highlight the recent wave of analyst favorability toward Enliven's stock. As of April 17, 2024, the average one-year price target for Enliven was documented at $35.02, representing a 10.75% rise from earlier estimates. This positive reassessment by analysts points to a robust sentiment surrounding Enliven Therapeutics' anticipated financial performance and its strategic direction in the months ahead.

Jefferies Lowers Price Target for Flowers Foods Amid Retail Pressures

Jefferies Lowers Price Target for Flowers Foods Amid Retail Pressures

20 minutes agoFLO

Jefferies recently revised its price target for Flowers Foods (NYSE: FLO) from $20 to $16, while maintaining a 'Hold' rating. This change comes as the company faces increased retail volume pressures, particularly in the bread category during the holiday season, as highlighted by Jefferies analyst Rob Dickerson. Reuters reported that these challenges are more pronounced now compared to the third quarter. The analyst pointed out that despite Flowers Foods ramping up promotional efforts, along with its competitors, there are concerns regarding the necessity of deep promotions to achieve sustainable volume growth. This suggests a challenging landscape for maintaining sales without sacrificing profit margins. Despite these pressures, Flowers Foods boasts strong financial health with a current ratio of 1.24 and a solid record of increasing dividends for 11 consecutive years. Furthermore, its recent $795 million acquisition of Simple Mills is a strategic move to diversify and expand into the snacking market. The 'Hold' rating reflects a balanced view, acknowledging both the company's robust fundamentals and the hurdles posed by the competitive market environment.

Jefferies Lowers Adobe Price Target Amid AI Monetization Concerns

Jefferies Lowers Adobe Price Target Amid AI Monetization Concerns

35 minutes agoADBE

Jefferies has adjusted its outlook on Adobe, reducing the price target from $700 to $650 while maintaining a 'Buy' rating, as reported by Nasdaq. The key concern for the adjustment centers around Adobe's ability to effectively monetize its generative AI technologies. While the company's strategic outlook remains positive, investors are awaiting more concrete results. Additionally, Adobe's fiscal 2025 revenue guidance, projected to be between $23.3 billion and $23.55 billion or about 9% growth, is seen as conservative by Jefferies, according to Wall Street Jedi. Despite this cautious guidance, Jefferies notes that Adobe has a history of issuing conservative forecasts and later surpassing them. Jefferies' commentary reflects unease over Adobe's immediate growth potential against the backdrop of a broader technological transition. Historically, Adobe has often outperformed its initial conservative guidance, indicating a possible reassurance for investors familiar with its strategic execution.

Broadcom Stock Slides Amid Market Volatility

Broadcom Stock Slides Amid Market Volatility

50 minutes agoAVGO

Broadcom Inc.'s stock is experiencing a downturn, currently trading at $228.61, marking a 1.77% decline from its previous closing price. This movement comes amidst increased market volatility following a recent U.S. credit rating downgrade by Moody's, which has had ripple effects across the financial markets. The stock opened at $232.64 and witnessed an intraday high and low of $233.54 and $223.08, respectively. With an intraday volume of 23,094,606, Broadcom shares have reacted to the broader market uncertainties influencing investor decisions. Reuters pointed out that such external economic pressures might be affecting the trading performance. Broadcom has not yet issued a formal response to these recent market developments. As the company continues to navigate these challenging market conditions, investors are advised to keep a watchful eye on any further announcements or strategic adjustments that Broadcom might make in response to the credit rating changes.